Mark A. Preston
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Urology top 1%
- Rheumatology top 5%
- Co-authors
- Quoc‐Dien TrinhAdam S. KibelToni K. ChoueiriMani MenonJoaquim BellmuntSteven L. ChangMaxine SunJeffrey J. Leow
- Topics
- Bladder and Urothelial Cancer Treatments (60 papers)Urinary and Genital Oncology Studies (40 papers)Prostate Cancer Treatment and Research (29 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark A. Preston
117 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Surgery 1.6k
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 615
- Urology 386
- Rheumatology 305
Countries citing papers authored by Mark A. Preston
This map shows the geographic impact of Mark A. Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Preston more than expected).
Fields of papers citing papers by Mark A. Preston
This network shows the impact of papers produced by Mark A. Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Preston. The network helps show where Mark A. Preston may publish in the future.
Co-authorship network of co-authors of Mark A. Preston
This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Preston. A scholar is included among the top collaborators of Mark A. Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Preston. Mark A. Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 12 | |
| 9 | 87 | |
| 10 | 11 | |
| 11 | 51 | |
| 12 | 41 | |
| 13 | 15 | |
| 14 | 49 | |
| 15 | 6 | |
| 16 | 77 | |
| 17 | 9 | |
| 18 | 46 | |
| 19 | 22 | |
| 20 | Leveraging the Cloud for Green IT: Predicting the Energy, Cost and Performance of Cloud Computing. | 10 |
About Mark A. Preston
Mark A. Preston is a scholar working on Urology, Surgery and Pulmonary and Respiratory Medicine, having authored 123 papers that have together received 2.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (60 papers), Urinary and Genital Oncology Studies (40 papers) and Prostate Cancer Treatment and Research (29 papers). The work is most often cited by research in Urology (386 citations), Surgery (1.6k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Mark A. Preston has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Quoc‐Dien Trinh, Adam S. Kibel, Toni K. Choueiri, Mani Menon, Joaquim Bellmunt, Steven L. Chang, Maxine Sun, Jeffrey J. Leow, Thomas Seisen and Alexander P. Cole. Their work appears in journals such as Journal of Clinical Oncology, Diabetes Care and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.